14770-82-2 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Methyl-2-thiophenamine is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to serve as a building block for the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Chemical Research:
In the realm of chemical research, 4-Methyl-2-thiophenamine is employed as a valuable compound for studying the properties and reactions of thiophenamines. Its use aids in expanding the understanding of organic chemistry and the development of novel chemical reactions and processes.
Used in Industrial Applications:
4-Methyl-2-thiophenamine also finds application in various industrial processes, where its chemical properties are harnessed for specific technical purposes. These applications may include the production of specialty chemicals, materials, or as part of larger chemical processes in the industry.
Given the compound's classification as a hazardous substance, it is crucial to follow proper safety protocols during its production, use, and disposal to mitigate any potential risks to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 14770-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,7,7 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 14770-82:
(7*1)+(6*4)+(5*7)+(4*7)+(3*0)+(2*8)+(1*2)=112
112 % 10 = 2
So 14770-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NS/c1-4-2-5(6)7-3-4/h2-3H,6H2,1H3
14770-82-2Relevant academic research and scientific papers
Methods for inhibiting protein kinases
-
Page/Page column 151, (2010/11/27)
The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim-1 kinase, and tyrosine kinase using imidazo[1,2-a]pyrazine compounds and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with protein kinases using such compounds.
Imidazopyrazines as protein kinase inhibitors
-
Page/Page column 77, (2010/11/27)
In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or checkpoint kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or checkpoint kinases using such compounds or pharmaceutical compositions.
